Suppr超能文献

Toll 样受体 4 多态性与 2 型糖尿病的关联。

Association of toll-like receptor 4 polymorphisms with type 2 diabetes mellitus.

机构信息

Department of Endocrinology, The General Hospital of Jinan Military Command, 25 Shifan Road, Jinan, Shandong, 250031, China.

出版信息

Inflammation. 2013 Feb;36(1):251-7. doi: 10.1007/s10753-012-9541-7.

Abstract

Type 2 diabetes mellitus (T2DM) is characterized by a chronic low-grade inflammatory state. Toll-like receptor 4 (TLR4) is a critical mediator of innate immunity. Polymorphisms in TLR4 gene have been shown to be associated with impaired inflammatory response. Here, we investigated the association of TLR4 polymorphisms with T2DM. Four TLR4 polymorphisms (+986A/G, +1196C/T, +3725G/C, and +11367G/C) were genotyped in a total number of 822 T2DM patients and 835 healthy controls. Results showed that the +986A/G and +1196C/T polymorphisms did not exist in the Han Chinese population. The prevalence of TLR4 +3725GC and CC genotypes were significantly decreased in T2DM cases than in controls (odds ratio (OR) = 0.62, 95 % confidence interval (CI) = 0.50-0.78, p = 3.48 × 10(-5), and OR = 0.36, 95 % CI = 0.22-0.59, p = 1.55 × 10(-5), respectively). Also, the frequency of TLR4 +3725C allele was significantly lower in T2DM patients (p = 2.46 × 10(-9)). When analyzing the TLR4 +11367G/C polymorphism, the +11367CC genotype revealed lower numbers in patients compared to healthy controls (OR = 0.46, 95 % CI = 0.27-0.78, p = 0.0032). Analysis of the clinical features on the control subjects demonstrated no correlations between these TLR4 polymorphisms and sex, age, body mass index, etc. (p > 0.05). In conclusion, these data indicate that TLR4 +3725G/C and +11367G/C polymorphisms may be novel protective factors against T2DM in the Chinese population.

摘要

2 型糖尿病(T2DM)的特征是慢性低度炎症状态。Toll 样受体 4(TLR4)是先天免疫的关键介质。TLR4 基因的多态性已被证明与炎症反应受损有关。在这里,我们研究了 TLR4 多态性与 T2DM 的关系。共对 822 例 T2DM 患者和 835 例健康对照者的 TLR4 4 个多态性(+986A/G、+1196C/T、+3725G/C 和 +11367G/C)进行了基因分型。结果表明,汉族人群中不存在 +986A/G 和 +1196C/T 多态性。TLR4 +3725GC 和 CC 基因型在 T2DM 患者中的发生率明显低于对照组(比值比(OR)=0.62,95%置信区间(CI)=0.50-0.78,p=3.48×10(-5),OR=0.36,95%CI=0.22-0.59,p=1.55×10(-5))。此外,TLR4 +3725C 等位基因在 T2DM 患者中的频率明显降低(p=2.46×10(-9))。在分析 TLR4 +11367G/C 多态性时,与健康对照组相比,+11367CC 基因型的患者数量较低(OR=0.46,95%CI=0.27-0.78,p=0.0032)。对对照组的临床特征进行分析表明,这些 TLR4 多态性与性别、年龄、体重指数等无相关性(p>0.05)。总之,这些数据表明 TLR4 +3725G/C 和 +11367G/C 多态性可能是中国人 2 型糖尿病的新保护因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验